Email This Article

Headlines & Perspectives
Panel Endorses Merck's Zostavax
By Robert Steyer
12/15/05 - 05:55 PM EST
The FDA panel restricted its recommendation to people age 60 and older.
Recipient's Email Address(es)
(Separate multiple addresses with a comma)
Your Email Address
Send a copy to myself
Your Message (optional)

Privacy Policy

The information entered on this page will not be used to send unsolicited email and will not be sold to a 3rd party.

Dow Jones S&P 500 NASDAQ 10-Year Note
10,495.01 1,115.92 2,202.05 33.88
Oil *
78.62
UP
42.33
UP
6.68
UP
17.02
UP
0.65
10 Yr
3.39%
SPDR Gold
119.04
+0.40%
+0.60%
+0.78%
+1.96%
Data delayed 20 minutes

Brokerage Partners